See also this year's filing and all EDGAR filings for this company.
PDF Report 0001583107_2018_Theravance_Biopharma_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001583107, Theravance Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 378,749,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 10,157,000 |
| 3 | remainder_Assets | 52,494,000 |
| 4 | LiabilitiesCurrent | 62,552,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 95,592,000 |
| 9 | ResearchAndDevelopmentExpense | 173,887,000 |
| 10 | remainder_Expenses | 36,271,000 |
| 11 | remainder_Revenues | 15,386,000 |
| 12 | remainder_NetIncome | 4,959,000 |
| 13 | remainder_ComprehensiveNetIncome | -480,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 441,400,000 |
| 1 | Liabilities | 62,552,000 |
| 2 | Expenses | 305,750,000 |
| 3 | Revenues | 15,386,000 |
| 4 | StockholdersEquity | 378,848,000 |
| 5 | NetIncome | -285,405,000 |
| 6 | ComprehensiveNetIncome | -285,645,000 |
| 7 | BaseVar | 415,263,500 |
| 8 | EconomicCapitalRatio | 1.45 |
Edgar->Model Mapping
Feature Distribution
Change over Time
